‘Cow flu’ has been spreading for two years — scientists still don’t understand it
In early 2024, a strain of bird flu turned up in American dairy herds. Since then it has spread across dozens of states, infected a handful of humans, and left researchers with…
It started in spring 2024 with sick cattle on dairy farms in Texas. The diagnosis was H5N1 — the bird flu variant that has long worried virologists for its lethality in birds and its potential to jump to humans. But cattle? That was unexpected. Cows were not considered a significant reservoir for influenza viruses. Yet the pathogen spread rapidly from state to state through routes that epidemiologists still haven’t fully mapped.
A review article in the April 2026 issue of Science draws an uncomfortable conclusion: two years after what researchers now call ‘cow flu’ emerged, the fundamental questions about transmission, host biology, and pandemic potential remain largely unanswered. Not for lack of scientific effort, but because research has been systematically obstructed — by inadequate surveillance systems, farmer reluctance to cooperate, and restricted access to infected farms.
Why this matters for aging and immune resilience
For a longevity audience, there is a less obvious angle here. Influenza is not an equal-opportunity disease. Older adults are disproportionately vulnerable to severe influenza infections, and that vulnerability is directly tied to immunosenescence — the gradual decline in immune function that accompanies aging. T-cell responses slow down, antibody production weakens, and the innate immune system becomes chronically inflamed but functionally less effective. If H5N1 ever achieves efficient human-to-human transmission, the burden on older populations would be severe.
This is not a hypothetical concern. In the 1918 Spanish flu pandemic and in seasonal influenza, older adults die in disproportionate numbers. The question of what a more dangerous influenza strain would do in an aging population already operating with compromised immune function is one longevity researchers cannot afford to ignore. Interventions that support immune function in older age — from improved vaccine strategies to immunomodulatory approaches currently being studied in longevity research — become more relevant in this context, not less.
What we don’t know — and why that’s dangerous
The most troubling aspect of the Science review is not what is known about cow flu, but what remains unclear after two years of active spread. How transmissible is the virus to humans? Through which routes does it infect cattle? How widespread is human infection among farmworkers in contact with infected animals? These questions remain imprecisely answered, partly because systematic surveillance in the United States was incomplete and inconsistent. For a world that claims to have learned lessons from COVID-19, that is a difficult finding to sit with.